NCT04230226

Acute Study on Muscle Soreness, Damage, and Performance

A Randomized, Double-blind, Placebo Controlled, Single-center Study to Determine the Effects of Pre-workout and Recovery Formulations on Soreness, Performance, Tolerance and Safety Outcomes in Healthy Adults Undergoing Training Program

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 32 (actual)
• Sponsor: Pharmanex · Industry
• Sex: All
• Age: 25 Years – 50 Years
• Healthy volunteers: Accepted

Summary

The acute study will evaluate pre- and post-exercise ingestion of a multi-ingredient supplement in a randomized, double-blind, placebo-controlled, crossover design. Participants will complete one enrollment visit, in which they will sign a consent form and complete a health history questionnaire. Participants will complete two interventions, with three visits each (6 visits total), in which a treatment beverage (pre/post supplement, or non-caloric placebo) will be consumed within 30 minutes prior to exercise and within 15 minutes post-exercise, in random order. Total time from enrollment to completion will be at least 14 days. Testing visits will be separated by a minimum of 7 days of rest to allow for recovery and washout, based on a half-life of ≤8 hours for all ingredients present in the supplement.

Conditions

• Soreness, Muscle
• Performance Enhancing Product Use
• Damage Muscle

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Pre-workout plus and protein recovery plus	Study products consumed prior and after exercise
OTHER	Placebo	Placebo product consumed prior and after exercise

Timeline

• Start date: 2020-01-21
• Primary completion: 2020-09-16
• Completion: 2020-09-16
• First posted: 2020-01-18
• Last updated: 2020-11-17

Locations

1 site across 1 country: United States